Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
Navidea Biopharmaceuticals (NAVB)
NYSE MKT:NAVB
Navidea (NAVB) Financial Statements
279 Followers
Navidea Financial Overview
| Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | |
|---|---|---|---|---|---|
| Income Statement | - | ||||
| Total Revenue | - | - | $ 610.00 | $ 7.52K | $ 6.52K |
| Gross Profit | - | - | $ -49.43K | $ -126.92K | $ 6.05K |
| EBIT | $ -1.23M | $ 2.41M | $ -3.24M | $ -4.95M | $ -2.92M |
| EBITDA | $ -1.09M | $ 2.38M | $ -3.29M | $ -4.93M | $ -2.90M |
| Net Income Common Stockholders | $ 5.82M | $ 3.37M | $ -3.48M | $ -7.75M | $ -3.00M |
| Balance Sheet | - | ||||
| Cash, Cash Equivalents and Short-Term Investments | $ 6.14M | $ 33.80K | $ 2.00M | $ 4.60M | $ 328.01K |
| Total Assets | $ 8.22M | $ 2.37M | $ 4.37M | $ 6.26M | $ 2.50M |
| Total Debt | $ 1.34M | $ 354.37K | $ 2.44M | $ 1.82M | $ 840.78K |
| Net Debt | $ -4.81M | $ 320.58K | $ 439.76K | $ -2.78M | $ 512.76K |
| Total Liabilities | $ 9.01M | $ 11.92M | $ 12.51M | $ 10.93M | $ 6.74M |
| Stockholders Equity | $ -1.08M | $ -9.84M | $ -8.44M | $ -4.96M | $ -4.53M |
| Cash Flow | - | ||||
| Free Cash Flow | $ 4.63M | $ -1.76M | $ -2.51M | $ -1.94M | $ -2.26M |
| Operating Cash Flow | $ 4.69M | $ -1.72M | $ -2.43M | $ -1.86M | $ -2.14M |
| Investing Cash Flow | $ -65.00K | $ -39.41K | $ -72.04K | $ -78.93K | $ -121.19K |
| Financing Cash Flow | $ 1.48M | $ -200.54K | $ -99.76K | $ 6.21M | $ 1.37M |